Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMOQKAD)

Drug Name

SNF472 Drug Info

Synonyms

Hexasodium phytate; UNII-ZBX50UG81V; 34367-89-0(Hexasodium phytate); ZBX50UG81V; 34367-89-0; sodium cyclohexane-1,2,3,4,5,6-hexayl hexakis(hydrogen phosphate); Inositol, hexakis(dihydrogen phosphate) hexasodium salt, myo-; Myo-inositol, hexakis(dihydrogen phosphate), hexasodium salt; Q27295268; scyllo-inositol,1,2,3,4,5,6-hexakis(dihydrogenphosphate),hexasodiumsalt; (1R,2R,3S,4S,5S,6S)-cyclohexane-(1,2,3,4,5,6)-hexaylhexakis(hydrogenphosphate),hexasodiumsalt

Indication

Disease Entry	ICD 11	Status	REF
Calcific uremic arteriolopathy	EB90.42	Phase 3	[1]
Calciphylaxis	EB90.42	Phase 3	[1]

Cross-matching ID

PubChem CID: 91667962
CAS Number: CAS 34367-89-0
TTD Drug ID: DMOQKAD

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hydroxyapatite (HA)	TTGUHMF	NOUNIPROTAC	Binder	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04195906) Phase 3 Study of SNF472 for Calciphylaxis (Calciphyx). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Sanifit.